Tag Archives: European Union

EU Health Commissioner Emerges from the Dark

By Julian Upton | Published: December 13, 2010
After a period of near invisibility, the EU’s health commissioner John Dalli has begun to make some higher profile appearance. Pharm Exec’s Europe correspondent Reflector assesses how these have been received by the pharma industry. Just before the holiday break, John Dalli, the European Union’s unobtrusive commissioner for health, has at last emerged from obscurity to [...]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , | 1 Comment

And What Exactly is a Stakeholder?

By Julian Upton | Published: August 19, 2010
Pharma’s uncritical use of the word ‘stakeholder’ has increased to the point where it can refer to almost anyone connected to the industry. But this can have serious consequences, warns Reflector. Like it or not (and frankly, I don’t), stakeholders are here to stay in European pharmaceutical affairs. Don’t get me wrong. I’ve no objection to [...]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , , , , | 1 Comment

Europe: Resisting the Anticompetitive Crusade

By Julian Upton | Published: July 23, 2010
It’s been another rocky few weeks for pharma in Europe. Particularly for big brand name companies. But necessity is proving the mother of invention, says Pharm Exec’s Brussels correspondent, Reflector. AstraZeneca suffered a serious setback at the start of July when the European General Court ruled that it had illegally prevented generic competition. The case dates [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment

HTA Concerns From European Drug Agency

By Julian Upton | Published: June 18, 2010
The EMA’s Thomas Lönngren has gone public with his disquiet over organizations such as NICE. But pharma still needs more allies in fighting what it sees as the failings of the health technology assessment bodies, says Pharm Exec Europe’s Brussels correspondent, Reflector. Europe’s pharmaceutical firms were never very keen on Britain’s influential National Institute for Health [...]
Posted in Europe, Global, Guest Blog, Regulatory, Safety, Strategy | Also tagged , , , | Leave a comment

Nothing is Rotten in the State of Denmark

By Julian Upton | Published: March 2, 2010
Guest blog by Reflector, Pharm Exec Europe’s Brussels correspondent. Denmark is still on the fringes of some European Union policies. Notably, it has not yet embraced the euro as a currency, and it keeps its distance from the common defence policy. But in one respect, its pharmaceutical industry has just shown that it is well abreast [...]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , , , | Leave a comment